Dehydroepiandrosterone administration before IVF in poor responders: a prospective cohort study

Reproductive BioMedicine Online - Tập 30 - Trang 191-196 - 2015
Nikos Vlahos1,2, Maria Papalouka3, Olga Triantafyllidou3, Athanasios Vlachos1, Panagiotis Vakas1, Gregory Grimbizis2,4, George Creatsas1, Konstantinos Zikopoulos2,5
12nd Department of Obstetrics and Gynecology, Aretaieion Hospital, University of Athens, Vas. Sofias str. 7, 11528, Greece
2Research Network for the evaluation of DHEA administration in poor responders, University of Athens, Aristoteleion University of Thessaloniki, University of Ioannina, Greece
3Reproductive Medicine Unit, “Lito” Maternity Hospital, Mouson str. 7-13, Athens 11524, Greece
4Department of Obstetrics and Gynecology, Aristoteleion University, Konstantinoupoleos str. 49, Thessaloniki 54642, Greece
5Department of Obstetrics and Gynecology, University of Ioannina, Dodoniw str. 22, 45332, Greece

Tài liệu tham khảo

Alpha Scientists in Reproductive and Embryology ESIGo, 2011, The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting, Hum. Reprod, 26, 1270, 10.1093/humrep/der037 Alviggi, 2006, Exploiting LH in ovarian stimulation, Reprod. Biomed. Online, 12, 221, 10.1016/S1472-6483(10)60865-6 Barad, 2005, Increased oocyte production after treatment with dehydroepiandrosterone, Fertil. Steril, 84, 756, 10.1016/j.fertnstert.2005.02.049 Barad, 2006, Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF, Hum. Reprod, 21, 2845, 10.1093/humrep/del254 De Placido, 2006, Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian response, Fertil. Steril, 85, 247, 10.1016/j.fertnstert.2005.07.1280 Ferraretti, 2011, ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria, Hum. Reprod, 26, 1616, 10.1093/humrep/der092 Gleicher, 2008, Androgen priming before ovarian stimulation for IVF, Hum. Reprod, 23, 2868, 10.1093/humrep/den319 Gleicher, 2011, Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR), Reprod. Biol. Endocrinol, 9, 67, 10.1186/1477-7827-9-67 Gleicher, 2009, Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study, Reprod. Biol. Endocrinol, 7, 108, 10.1186/1477-7827-7-108 Gleicher, 2010, Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS), Reprod. Biol. Endocrinol, 8, 140, 10.1186/1477-7827-8-140 Gleicher, 2010, Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation, Reprod. Biomed. Online, 21, 360, 10.1016/j.rbmo.2010.04.006 Hyman, 2013, DHEA supplementation may improve IVF outcome in poor responders: a proposed mechanism, Eur. J. Obstet. Gynecol. Reprod. Biol, 168, 49, 10.1016/j.ejogrb.2012.12.017 Kolibianakis, 2011, DHEA administration in poor responders, Hum. Reprod, 26, 730, 10.1093/humrep/deq397 Madani, 2012, Comparison of different stimulation protocols efficacy in poor responders undergoing IVF: a retrospective study, Gynecol. Endocrinol, 28, 102, 10.3109/09513590.2011.579206 Narkwichean, 2013, Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysis, Reprod. Biol. Endocrinol, 11, 44, 10.1186/1477-7827-11-44 Pandian, 2010, Interventions for ‘poor responders’ to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF), Cochrane Database Syst. Rev, 10.1002/14651858.CD004379.pub3 Polyzos, 2011, A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel?, Fertil. Steril, 96, 10.1016/j.fertnstert.2011.09.048 Sunkara, 2011, Androgen pretreatment in poor responders undergoing controlled ovarian stimulation and in vitro fertilization treatment, Fertil. Steril, 95, e73, 10.1016/j.fertnstert.2011.04.083 Sunkara, 2011, Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis, Reprod. Biomed. Online, 22, 545, 10.1016/j.rbmo.2011.01.015 Urman, 2012, DHEA for poor responders: can treatment be justified in the absence of evidence?, Reprod. Biomed. Online, 25, 103, 10.1016/j.rbmo.2012.05.009 Vendola, 1998, Androgens stimulate early stages of follicular growth in the primate ovary, J. Clin. Invest, 101, 2622, 10.1172/JCI2081 Vendola, 1999, Androgens promote insulin-like growth factor-I and insulin-like growth factor-I receptor gene expression in the primate ovary, Hum. Reprod, 14, 2328, 10.1093/humrep/14.9.2328 Vendola, 1999, Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary, Biol. Reprod, 61, 353, 10.1095/biolreprod61.2.353 Vollenhoven, 2008, Is there an ideal stimulation regimen for IVF for poor responders and does it change with age?, J. Assist. Reprod. Genet, 25, 523, 10.1007/s10815-008-9274-6 Weil, 1999, Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development, J. Clin. Endocrinol. Metab, 84, 2951, 10.1210/jcem.84.8.5929 Wiser, 2010, Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study, Hum. Reprod, 25, 2496, 10.1093/humrep/deq220 Yeung, 2013, A randomized double-blinded placebo-controlled trial on the effect of dehydroepiandrosterone for 16 weeks on ovarian response markers in women with primary ovarian insufficiency, J. Clin. Endocrinol. Metab, 98, 380, 10.1210/jc.2012-3071